Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Calyxt Inc - SIC # 5499 - MISCELLANEOUS FOOD STORES
Ticker
Exchange
SIC #
Website
Latest Ticker
CLXT
Nasdaq
5499
https://calyxt.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Calyxt Inc
Calyxt Announces Stockholder Approval of Merger With Cibus
- May 19th, 2023 8:01 pm
Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update
- May 1st, 2023 8:01 pm
Calyxt Completes One-for-Ten Reverse Stock Split
- Apr 24th, 2023 8:35 pm
Calyxt, Inc. Announces Effectiveness of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC
- Apr 18th, 2023 8:05 pm
Calyxt Announces Effective Date of Reverse Stock Split
- Apr 7th, 2023 8:05 pm
Calyxt, Inc. Reports its Fourth Quarter 2022 Financial Results and Provides Corporate Update
- Mar 6th, 2023 9:30 pm
Calyxt Reports Fourth Quarter 2022 Financial Results and Provides Corporate Update
- Mar 2nd, 2023 9:01 pm
Calyxt, Inc. Announces its Filing of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC
- Feb 15th, 2023 12:30 pm
Plant-based biotech company Calyxt to merge with California firm
- Jan 17th, 2023 8:37 pm
Calyxt Shares Surge On Merger Agreement Creating Agriculture-Focused Precision Gene Editing Company
- Jan 17th, 2023 1:32 pm
Calyxt and Cibus Announce the Signing of a Definitive Merger Agreement
- Jan 17th, 2023 12:10 pm
Calyxt and Cibus Announce Definitive Merger Agreement to Create Industry-Leading Precision Gene Editing and Trait Licensing Company
- Jan 17th, 2023 11:30 am
Calyxt Achieves Phase 1 Milestone in Collaboration Agreement to Develop Alternative to Palm Oil
- Nov 18th, 2022 4:00 pm
Calyxt Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule
- Nov 17th, 2022 9:01 pm
Calyxt Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag
- Nov 9th, 2022 12:05 pm
Calyxt (CLXT) Reports Q3 Loss, Misses Revenue Estimates
- Nov 3rd, 2022 9:45 pm
Calyxt Reports Third Quarter 2022 Financial Results and Provides Corporate Update
- Nov 3rd, 2022 8:01 pm
Calyxt Joins Bioindustrial Manufacturing and Design Ecosystem (BioMADE), a Department of Defense Initiative, to Advance Sustainable Plant-Based Biomanufacturing
- Nov 1st, 2022 11:00 am
Calyxt to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 3, 2022, at 4:30 p.m. Eastern Time
- Oct 27th, 2022 11:00 am
Calyxt Successfully Produces Plant-Based Squalene, an Important Ingredient in Personal Care Products and Critical Vaccine Adjuvants
- Oct 25th, 2022 11:00 am
Scroll